While the top- and bottom-line numbers for Ares Commercial Real Estate (ACRE) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ares Commercial Real Estate (ACRE) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.19. This compares to earnings of $0.35 per share a year ago.
Dividends need to be sustained to create value. We're highlighting a company that regularly falls short. I made some mistakes many years ago and I want to address them so we can all learn from them.
Accounting is driving a failure of efficient markets. The persistency of this market failure is absurd. Investors love LIBOR swaps and don't care for other tools that serve the same purpose. DX and AGNC are much more similar than investors think. This is primarily due to being clueless about accounting.
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the second quarter ended June 30, 2024 on August 6, 2024 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m.
After a terrible start to the year, mortgage REITs are hot in July. Don't tell ORC. They missed most of the rally. If only it was an opportunity to destroy book value. They're so good at that. Quick commentary on MAIN.
U.S. equity markets posted their worst week since April while benchmark interest rates rebounded from four-month lows as a wild week of political developments sparked a surge in volatility. Markets reflected a higher likelihood of a conservative victory after former President Trump survived an assassination attempt last weekend, adding fuel to the rotation from multinational growth towards value-oriented domestic. The tech-heavy Nasdaq 100 slid 4% on the week, as tech-specific concerns compounded pre-existing macroeconomic dynamics, but small-cap and mid-cap indices outperformed.
This is a head-to-head battle between two of the high yielders. Both are at least over 12%. This is a lesson in evaluating similar shares for differences in valuation. The emphasis here is on the change in valuation. These shares should have similar valuations, but they don't.
Dividend yields from 13.2% to 17.4%. Two of these stocks are awful. Pair trade? I keep buying one of the REITs. Hopefully, it isn't one of the awful ones. That would be awful.
Management tried to keep the dividend down. They have the cash to pay out. These shares ranked ahead of the common shares. We've invested in these shares before. Now we're doing it again. Except this time, we're putting even more money in.
We spotted a new baby bond that was particularly appealing. A discount to face value drove yields higher. When we consider these high-yielding investments, it's important to carefully compare them with other opportunities. We'll do that here. We closed out one of our other high-yielding positions to lock in a substantial gain.
Ares Commercial Real Estate experienced deteriorating distribution coverage due to realized losses on impaired loans in Q1'24. The REIT's $2.0B loan portfolio includes 8 impaired loans, with the majority of its CECL reserve relating to office loans. The increased likelihood of another dividend cut is reflected in Ares Commercial Real Estate's large discount to book value.